Liberty Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-24
Closed -$4K 389
2021
Q3
$4K Buy
24
+12
+100% +$1.76K ﹤0.01% 969
2021
Q2
$2K Sell
12
-259
-96% -$33.9K ﹤0.01% 909
2021
Q1
$36K Hold
271
0.02% 344
2020
Q4
$36K Sell
271
-9
-3% -$1.1K 0.02% 341
2020
Q3
$32K Sell
280
-19
-6% -$2.25K 0.02% 315
2020
Q2
$34K Buy
299
+284
+1,893% +$30.1K 0.02% 282
2020
Q1
$1K Hold
15
﹤0.01% 783
2019
Q4
$2K Hold
15
﹤0.01% 762
2019
Q3
$2K Hold
15
﹤0.01% 732
2019
Q2
$2K Hold
15
﹤0.01% 754
2019
Q1
$1K Buy
+15
New +$1.3K ﹤0.01% 664

Other funds holding DGX

Liberty Wealth Management's DGX Position: Q4 2021 in Review

Liberty Wealth Management sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 24 shares — an estimated $4K sold.

Liberty Wealth Management first reported a position in DGX in Q1 2019 and held it in 11 quarters. The position peaked at $36K in Q1 2021. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.

  • Liberty Wealth Management reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 24 Quest Diagnostics shares in Q4 2021, an estimated $4K.
  • Liberty Wealth Management first reported a position in Quest Diagnostics in Q1 2019 and held it in 11 quarters.
  • Liberty Wealth Management's Quest Diagnostics position peaked at $36K in Q1 2021.
  • 905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.